April 29, 2021

European Delegation law to implement the Medical Devices Regulations

Thanks to Giulia Conforto for collaborating on this article

On April 23, Law No. 53 of April 22, 2021, Delegation to the Government for the transposition of European directives and the implementation of other European Union acts,” was published in the Official Gazette (“Delegation Law”).

Article 15 of the Delegation Law provides principles and criteria for the government to use in adapting the national regulatory framework to the provisions of the Medical Devices Regulations (EU Regulations 2017/745 and 2017/746) by issuing one or more legislative decrees within the next 12 months.

According to the principles and criteria established by the Delegation Law, the government will have to:

  • adapt to the EU Regulations existing national provisions concerning modalities and procedures for supervision, market surveillance, and safety oversight of medical devices, with express abrogation of any incompatible national provisions;
  • establish the contents, timing, and methods for recording information that manufacturers and distributors of medical devices, as well as users, are required to communicate to the Ministry of Health;
  • arrange for the reorganization and coordination of activities among the entities responsible for the governance of medical devices, including the reorganization of the mechanism to set public expenditure ceilings for the purpose of application of the payback system with respect to the medical devices sector, according to Law Decree 78/2015;
  • establish a sanctioning system through the provision of effective, dissuasive administrative sanctions proportionate to the severity of violation of the provisions of the Medical Devices Regulations (the sanctioning system will also have to provide for a reduction of one-third of the administrative penalty in the event of a breach committed by a micro-enterprise);
  • better identify the methods of traceability of medical devices through the reorganization and connection of existing or implementing databases in accordance with the Unique Device Identification System (UDI System) provided for by the EU Regulations;
  • make medical device purchasing procedures more efficient by strengthening Health Technology Assessment (HTA) procedures;
  • adapt the processing of personal data carried out pursuant to the Medical Devices Regulations to the provisions of Regulation (EU) 2016/679 (or GDRP) and to the current legislation on the protection of personal and sensitive data; and
  • introduce the obligation for companies that produce or market medical devices to pay a share of no more than 0.75% of their turnover resulting from sales of medical devices and large equipment, net of value-added tax, to the National Health Service for the purpose of financing the system for governance of medical devices.

Considering the above, it seems that the new legislative provisions to be issued for the main purpose of adapting the existing Italian regulatory framework to the EU Regulations on medical devices might present an opportunity to address certain general issues concerning the governance of medical devices in Italy.

< Back to blog
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.
Read more
Our highly-ranked team of professionals will provide newsinsights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

May 4, 2021
European Health Union: Commission publishes open public consultation on the European Health Data Space
April 22, 2021
Clinical Trial Regulation: Clinical trial EU Portal and Database, essential for the Clinical Trial Information System (CTIS), is now fully functional and on track to go live by 31 January 20...
January 19, 2021
Dematerialization of prescriptions: Ministerial Decree allowing e-prescriptions for drugs not reimbursed by the NHS has been published in the Italian Official Journal.
December 21, 2020
Telemedicine: Italian State-Regions Conference issues "National indications for the provision of telemedicine services" to implement telemedicine services in Italy
October 8, 2020
Ecommerce of medicinal products: according to the European Court of Justice, certain legislative restrictions imposed by the Member State where medicines are offered to public also apply to ...
Search by...
Follow us on
Follow us on